| 1 |
26320398 | Prevalence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA among methicillin-resistant S. aureus with high vancomycin minimal inhibitory concentrations in Taiwan: A multicenter surveillance study, 2012-2013. | 2016 Oct |
2 |
| 2 |
26143590 | Insights and clinical perspectives of daptomycin resistance in Staphylococcus aureus: A review of the available evidence. | 2015 Sep |
1 |
| 3 |
26430942 | Increasing Trend of Heterogeneous Vancomycin Intermediate Staphylococcus aureus in a Tertiary Care Center of Northern India. | 2015 Oct |
2 |
| 4 |
24217694 | In vitro pharmacodynamics of human simulated exposures of ceftaroline and daptomycin against MRSA, hVISA, and VISA with and without prior vancomycin exposure. | 2014 |
2 |
| 5 |
24329974 | hVISA and MRSA endocarditis: an 8-year experience in a tertiary care centre. | 2014 Oct |
2 |
| 6 |
24325260 | Vancomycin and daptomycin minimum inhibitory concentration distribution and occurrence of heteroresistance among methicillin-resistant Staphylococcus aureus blood isolates in Turkey. | 2013 Dec 10 |
1 |
| 7 |
22253738 | Modulating activity of vancomycin and daptomycin on the expression of autolysis cell-wall turnover and membrane charge genes in hVISA and VISA strains. | 2012 |
11 |
| 8 |
22495870 | Daptomycin resistance in prosthetic joint infections. | 2012 Apr |
1 |
| 9 |
21321148 | Impact of dose de-escalation and escalation on daptomycin's pharmacodynamics against clinical methicillin-resistant Staphylococcus aureus isolates in an in vitro model. | 2011 May |
2 |
| 10 |
21393156 | Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure. | 2011 May |
9 |
| 11 |
18984644 | Evaluation of vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus and heterogeneously vancomycin-intermediate S. aureus in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations. | 2009 Jan |
3 |
| 12 |
19744978 | Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals. | 2009 Nov |
1 |
| 13 |
19838095 | [Treatment of multiresistant Gram positive endocarditis]. | 2009 Jul |
1 |
| 14 |
17531446 | Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004). | 2007 Aug |
2 |
| 15 |
16801409 | Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin. | 2006 Jul |
2 |